Search
for

    Sort by

    Research 901–930 of 1000+

    1. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study The Journal of Clinical Endocrinology and Metabolism · 2015 · 71 citations
    2. Proposing a Simpler Classification of Telogen Effluvium Skin appendage disorders · 2016 · 21 citations
    3. Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome Hormone and Metabolic Research · 2019 · 3 citations
    4. Methods of Using of Cosmeceuticals in Trichological Practice 2026 · 1 citations
    5. Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies International Journal of Drug Delivery Technology · 2026
    6. Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society Przegla̧d dermatologiczny · 2018
    7. Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years Reproductive Biomedicine Online · 2017 · 6 citations
    8. Excessive hair loss in women. Evaluation of scalp therapy using injectable platelet-rich fibrin Aesthetic Cosmetology and Medicine · 2025
    9. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata JCI insight · 2016 · 222 citations
    10. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology · 2017 · 213 citations
    11. Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial Therapy · 2006 · 47 citations
    12. Skin disease in pregnancy The BMJ · 2014 · 34 citations
    13. Sperm aneuploidy in infertile male patients: a systematic review of the literature Andrologia · 2014 · 26 citations
    14. Androgenetic alopecia; drug safety and therapeutic strategies Expert Opinion on Drug Safety · 2018 · 20 citations
    15. Process Development and Crystallization in Oiling-Out System of a Novel Topical Antiandrogen Organic Process Research & Development · 2017 · 9 citations
    16. Exploring phytoandrogens: A review of their potential in health and medicine The Journal of Phytopharmacology · 2025 · 1 citations
    17. Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis Neurodegenerative disease management · 2013
    18. Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome International Journal of Molecular Sciences · 2020 · 58 citations
    19. Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease Internal Medicine Journal · 2005 · 129 citations
    20. Acquired scalp alopecia. Part II: A review Australasian Journal of Dermatology · 1999 · 37 citations
    21. The North American Menopause Society Recommendations for Clinical Care of Midlife Women Menopause · 2014 · 254 citations
    22. Group IID, IIE, IIF and III secreted phospholipase A2s Biochimica and biophysica acta. Molecular and cell biology of lipids · 2018 · 23 citations
    23. Toward Optimal Health: The Experts Respond to Hair Loss in Women Journal of women's health · 1998
    24. Types and Treatment of Hair Loss in Men and Women Plastic and Aesthetic Nursing · 2020 · 8 citations
    25. Teriflunomide (Aubagio®) for the treatment of multiple sclerosis Experimental Neurology · 2014 · 36 citations
    26. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents Drugs · 2019 · 90 citations
    27. Treatment of the adolescent patient with polycystic ovary syndrome Obstetrics and gynecology clinics of North America · 2003 · 26 citations
    28. Myo-Inositol (ProFecund Ino) – Obtaining a Pregnancy in Women with Polycystic Ovary Syndrome IntechOpen eBooks · 2024
    29. Safety of Common Medications for Treating Dermatology Disorders in Pregnant Women Current Dermatology Reports · 2013 · 7 citations
    30. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations Pharmaceutics · 2024 · 32 citations